Jon Otterstatter and the art of the controlled no

A company can have a grand ambition and a very ordinary problem: paying for next month. Jon Otterstatter had a phrase for the early arrangement at Preventice. “It’s what we call programming for food,” he said. The founders put in personal capital and sold technical services. Before the acquisition announcement, before the large financing rounds, there was work that brought money through the door.

The phrase has the merit of leaving the romance out of it. Software expertise could pay a bill. That gave a young business something useful alongside its plans: time. Otterstatter had already worked at IBM, ShowCase Corporation and SPSS. When he co-founded Preventice in 2007, he brought experience from established software businesses into the less settled business of starting another one.

Fourteen years later, Boston Scientific completed its acquisition of Preventice Solutions. The announced terms carried a $925 million upfront figure, with additional consideration tied to a commercial milestone. An opening chapter financed partly through service work had acquired a rather different set of numbers. Between those two moments lies a career worth examining through its working decisions, rather than its final price tag.

A programmer learns the size of the room

Otterstatter studied computer science at the University of Wisconsin-La Crosse and earned a master’s degree in technology management at MIT. The pairing makes sense beside the work that followed: understanding how software gets made, then accepting responsibility for the people and resources needed to make it. His career would repeatedly place technical choices alongside organizational ones.

At IBM, he served as a senior programming manager. At ShowCase, in Rochester, Minnesota, he held a senior technology leadership role. He then became executive vice president and chief technology officer at SPSS, where his responsibilities included worldwide technology operations. Strategy, budgets, personnel and daily execution sat within the same remit. A title can fit on a business card; that collection of obligations needs considerably more room.

By March 2001, he had begun his tenure as SPSS’s chief technology officer. He participated in research for a 2003 MIT thesis examining platform strategy. Its account places research, development and support under his responsibility, and describes his earlier ShowCase work on business intelligence products for IBM’s iSeries platform. Here was a software executive already occupied with the relationships between one company’s products and another company’s systems.

That background gives his later partnerships a useful context. Products live among other products. Customers have existing systems. A decision made elsewhere can change the conditions for your own work. Reading his career through that lens, the recurring task is getting a useful piece of technology to function within a larger commercial arrangement, with all the dependencies that arrangement brings.

Four founders, then a larger table

Preventice began with Otterstatter and three other founders in 2007. It was founded in Rochester, a city already present in his ShowCase career. Starting again after senior management posts meant moving from responsibility within an established organization to responsibility for establishing one. Even an experienced executive has to find customers, finance development and decide which opportunities a small team can actually support.

The company’s 2012 board announcement offers a glimpse of that expanding circle. Tadd Tobkin of Arthur Ventures joined the board after spearheading the firm’s initial investment in 2010. The announcement described a company with offices in Rochester, Fargo and Minneapolis, plus sales staff on both coasts. The enterprise was acquiring both a governance structure and a wider geographical footprint.

There is an organizational story in those details. Additional locations mean additional coordination. Investment brings people whose relationship to the business differs from a founder’s. A board introduces another forum in which plans must survive questions. The work of growing a company includes creating places where decisions can be challenged before they become expensive habits.

Otterstatter’s earlier management experience was relevant to this change in scale. He had already held responsibility for personnel and budgets across worldwide operations. A startup still requires its own answers, but he had encountered the practical problem behind expansion: how to keep separate teams working toward something coherent when the founder can no longer personally carry every conversation.

The investor on both sides of the table

Alongside his operating career, Otterstatter became a co-founder and managing partner of Vilicus Ventures. A 2013 investors’ rights agreement records his signature as managing partner on behalf of two Entrepreneurs Capital funds, with Vilicus as their general partner. It is a small documentary detail with a clear implication: his connection to venture investing extended into the formal responsibilities of managing capital.

The investing work also connected his career with his son Matt’s. Matt co-founded Vilicus in early 2012 and later completed the Kauffman Fellows program with Jon as his mentor. Their professional backgrounds differed. Matt had worked on rocket propulsion systems before moving into venture capital. Software and aerospace supplied rather different routes to the same investment table.

Mentorship gives this part of the story a personal dimension without requiring a family legend. Jon’s experience as an operator was available to someone entering a new profession. The relationship placed the work of judging companies beside the work of building them. Both require attention to people, execution and the distance between a promising idea and a functioning enterprise.

A founder’s next job can be helping someone else make the decisions.

A career in operating, investing and governance

When the numbers change the job

By early 2021, Preventice had approximately 1,000 employees. Its locations included Rochester and offices in North Dakota, California and Texas. For 2020, it had posted $158 million in net sales, an increase of about 30 percent over the previous year, and secured a $137 million Series B financing round. Those figures describe an operating organization with substantial demands on its management.

Revenue growth and funding belong in separate columns. Sales record business done; investment supplies capital under agreed terms. A company can need both while confronting different questions about each. For Otterstatter, the figures mark how far the organization had moved from its beginnings. The executive’s task now included keeping a sizable enterprise coordinated while handling relationships with investors and a prospective acquirer.

The numbers are useful because they complicate a familiar acquisition story. A buyer did not simply arrive to put a price on an idea. An organization had already formed around that idea, with employees, offices, sales and capital commitments. The purchase announcement made a convenient public milestone. Much of the work it recognized had taken place through decisions that rarely become headlines.

A partner becomes the buyer

Boston Scientific had invested in Preventice since 2015. By the acquisition announcement on January 21, 2021, it held approximately 22 percent of the company. This was a buyer with an existing financial relationship. The eventual transaction followed years of involvement, giving the sale a different shape from a first encounter between a founder and an unfamiliar bidder.

The acquisition closed on March 1, 2021. Its stated terms comprised $925 million upfront and up to $300 million in a potential commercial milestone payment. Accounting for the buyer’s existing stake, the closing announcement described approximately $720 million upfront and approximately $230 million in potential milestone consideration. The distinction matters: an acquisition headline and the new payment required from the buyer can describe different amounts.

For Otterstatter, the broader continuity is the presence of larger organizations throughout his career. He had worked inside IBM, directed technology operations at SPSS, raised capital for Preventice and led it through a sale to an existing investor. Each position came with a different balance of authority, resources and accountability. The company changed hands; the need to manage those relationships remained a recognizable thread.

The chair after the chief executive

His next chapter was already taking shape before the sale. Otterstatter joined Dakota REIT’s board of trustees in 2018 and became chair in June 2021. He also serves on its Investment Council. That sequence puts a useful correction into the familiar picture of an executive reaching an exit: some of the work that follows can begin years before the transaction closes.

Dakota REIT identifies him as an independent trustee. Its leadership biography also lists his board role at metroConnections. The move from running a company to chairing a board changes the relationship to decisions. A chief executive directs an organization’s operations. A trustee works within a structure of oversight, with obligations to the trust and its investors.

He had joined the Protenus board in March 2019, another appointment made while he was leading Preventice. In explaining the appeal, he singled out the combination of “product, team and market opportunity.” It is a compact description of what an experienced operator might examine: something worth selling, people capable of doing the work, and customers with a reason to buy.

Return, finally, to his phrase for handling a large partner’s requests: a “controlled no.” His description involved avoiding surprises, remaining respectful and finding what could be provided. There is room in that formulation for ambition and limits alike. Across software management, company building, investing and trusteeship, Otterstatter’s career suggests how much can depend on keeping a relationship useful while retaining the ability to make a decision.